SEC Form 4 · accession 0001144204-15-040949
CALADRIUS BIOSCIENCES, INC. · CLBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Douglas W Losordo
Officer — See Remarks
Period of report
Jun 30, 2015
Accepted (ET)
Jul 2, 2015 · 9:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000320017
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par valueF1 | Jun 30, 2015 | A | 6,369 | $1.5895 | A | 48,209 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares purchased pursuant to Caladrius Biosciences, Inc.'s 2012 Employee Stock Purchase Plan for the period ended June 30, 2015.
Remarks
Chief Medical Officer, Senior VP Clinical, Medical and Regulatory Affairs